1
关注
1026
浏览

接受者(合同授予者)如何对供应商(合同接受者)提供的分析证书(CoA)等文件的有效性建立信心?

您还未登录!暂时最多只可查看 1 条回答

登录! 还没有账号?去注册

trer234 一阶会员 用户来自于: 广东省深圳市
2023-10-26 22:47

 The recipient should have knowledge of the systems and procedures implemented at the supplier for the generation of the CoA. Arrangements should be in place to ensure that significant changes to systems are notified and the effectiveness of these arrangements should be subjected to periodic review.

接受者应了解供应商为生成CoA所实施的系统和程序。应做出安排,确保系统的重大变化得到通知,并对这些安排的有效性进行定期审查。

Data related to activities which are outsourced are routinely provided as summary data in a report format (e.g. CoA). These summary documents are reviewed on a routine basis by the contract acceptor and therefore the review of data integrity at the contract acceptor site on a regular periodic basis (e.g. during on-site audit) takes on even greater significance, in order to build and maintain confidence in the summary data provided.

与外包活动有关的数据通常以报告格式(如CoA)提供摘要数据。这些摘要文件由合同接受方进行例行审查,因此在合同接受方现场定期审查数据的完整性(例如在现场审计期间)具有更大的意义,以便建立和保持对所提供的摘要数据的信心。


关于作者

问题动态

发布时间
2023-10-26 22:47
更新时间
2023-10-26 22:47
关注人数
1 人关注

相关问题

Graphpad Prism纵坐标截断图如何绘制?
如何注册医疗器械软件?
一次性使用医用口罩、医用外科口罩、医用防护口罩申报不同型号规格如何选择典型型号进行注册检验?
纯钦或镇合金材料的骨科植入器械经着色阳极氧化处理后,如产品表面除基体元素外还含有残留杂质元素应如何进行生物学评价?
有源医疗器械主机包含一款外购的成熟工业模块(含软件),模块供应商不能提供完整的软件资料,该产品申报注册时应如何提交软件研究资料?
在生物等效性试验设计时,对于高变异药物,可根据参比制剂的个体内变异,将等效性评价标准作适当比例的调整,该如何操作 ?
茶叶的基体比较复杂,其铅含量在3PPM左右,先只有火焰原子吸收,0.1PPM的吸收值在0.007左右,请问如何解决其复杂基体问题?
工艺验证时如果这个产品没有含量项,如何确定产品的均匀性,必须得从处方中找一个有含量项的进行验证吗,可以用水份或粒度或PH值代替吗?
每年生产1〜2批的产品如何做工艺验证?验证方法用什么?
自eRPS系统启用后,通过线上途径进行的注册申报事项如何提交受理补充资料?

推荐内容

How should blank forms be controlled?
Is FDA allowed to look at electronic records?
What is “metadata”?
Who should review audit trails?
How does FDA recommend data integrity problems be addressed?
How does FDA use the term “backup” in § 211.68(b)?
Is it acceptable to only save the final results from reprocessed laboratory chromatography?
Determining CGMP data as invalid is not considered as a judgment of batch conformity?
How often should audit trails be reviewed?
数据生命周期":当数据(或结果)被用来做决策时,应考虑哪些风险?